| [1] |
DeSantis CE,Lin CC,Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014[J]. CA Cancer J Clin, 2014, 64(4): 252-271.
|
| [2] |
Mayo SC,Heckman JE,Shore AD, et al. Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis[J]. Surgery, 2011, 150(2): 204-216.
|
| [3] |
Andres A,Toso C,Adam R, et al. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study[J]. Ann Surg, 2012, 256(5): 772-778; discussion 778-779.
|
| [4] |
Ekberg H,Tranberg KG,Andersson R,et al. Determinants of survival in liver resection for colorectal secondaries[J]. Br. J. Surg, 1986, 73(9): 727-731.
|
| [5] |
Folprecht G,Gruenberger T,Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial[J]. The lancet oncology, 2010, 11(1): 38-47.
|
| [6] |
Rees M,Tekkis PP,Welsh FK, et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients[J]. Ann Surg, 2008, 247(1): 125-135.
|
| [7] |
Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases[J]. Annals of Oncology, 2003, 14(suppl 2): ii13-ii16.
|
| [8] |
Folprecht G,Gruenberger T,Bechstein W, et al. Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)[J]. Annals of Oncology, 2014, 25(5): 1018-1025.
|
| [9] |
Fong Y,Fortner J,Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases[J]. Annals of surgery, 1999, 230(2): 309-318.
|
| [10] |
Altendorf-Hofmann A,Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma[J]. Surg Oncol Clin N Am, 2003, 12(1): 165-192.
|
| [11] |
Nagashima I,Takada T,Adachi M, et al. Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors[J]. World Journal of Gastroenterology, 2006, 12(39): 6305-6309.
|
| [12] |
Yamaguchi T,Mori T,Takahashi K, et al. A new classification system for liver metastases from colorectal cancer in Japanese multicenter analysis[J]. Hepato-gastroenterology, 2008, 55(81): 173-178.
|
| [13] |
Malik HZ,Prasad KR,Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases[J]. Ann Surg, 2007, 246(5): 806-814.
|
| [14] |
Minagawa M,Yamamoto J,Kosuge T, et al. Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Archives of Surgery[J]. 2007, 142(3): 269-276.
|
| [15] |
Zakaria S,Donohue JH,Que FG, et al. Hepatic resection for colorectal metastases: value for risk scoring systems[J]? Ann Surg, 2007, 246(2): 183-191.
|
| [16] |
Tan MCB,Castaldo ET,Gao F, et al. A Prognostic System Applicable to Patients with Resectable Liver Metastasis from Colorectal Carcinoma Staged by Positron Emission Tomography with[18F]Fluoro-2-Deoxy-D-Glucose: Role of Primary Tumor Variables[J].Journal of the American College of Surgeons, 2008, 206(5): 857-868.
|
| [17] |
Konopke R,Kersting S,Distler M, et al. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases[J]. Liver Int, 2009, 29(1): 89-102.
|
| [18] |
Nordlinger B,Guiguet M,Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients[J]. Cancer, 1996, 77(7): 1254-1262.
|
| [19] |
Cady B,Jenkins RL,Steele Jr GD, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome[J]. Annals of surgery, 1998, 227(4): 566-571.
|
| [20] |
Choti MA,Sitzmann JV,Tiburi MF, et al. Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases[J]. Annals of Surgery, 2002, 235(6): 759-766.
|
| [21] |
Pawlik TM,Scoggins CR,Zorzi D, et al. Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases[J]. Annals of Surgery, 2005, 241(5): 715-724.
|
| [22] |
Postriganova N,Kazaryan AM,Røsok BI, et al. Margin status after laparoscopic resection of colorectal liver metastases: does a narrow resection margin have an influence on survival and local recurrence[J]? HPB: The Official Journal of the International HepatoPancreato Biliary Association, 2014, 16(9): 822-829.
|
| [23] |
Andreou A,Aloia TA,Brouquet A, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy[J]. Ann Surg, 2013, 257(6): 1079-1088.
|
| [24] |
de Haas RJ,Wicherts DA,Flores E, et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery[J]? Ann Surg, 2008, 248(4): 626-637.
|
| [25] |
Kato T,Yasui K,Hirai T, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions[J]. Diseases of the colon and rectum, 2003, 46(10 Suppl): S22-S31.
|
| [26] |
Elias D,Liberale G,Vernerey D, et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect[J]. Annals of surgical oncology, 2005, 12(11): 900-909.
|
| [27] |
Lehnert T,Knaebel HP,Dück M, et al. Sequential hepatic and pulmonary resections for metastatic colorectal cancer[J]. British Journal of Surgery, 1999, 86(2): 241-243.
|
| [28] |
Headrick JR,Miller DL,Nagorney DM, et al. Surgical treatment of hepatic and pulmonary metastases from colon cancer[J]. The Annals of Thoracic Surgery, 2001, 71(3): 975-980.
|
| [29] |
Miller G,Biernacki P,Kemeny NE, et al. Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases[J]. Journal of the American College of Surgeons, 2007, 205(2): 231-238.
|
| [30] |
Adam R,de Haas RJ,Wicherts DA, et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery[J]? Annals of surgery, 2011, 253(2): 349-359.
|
| [31] |
Masi G,Cupini S,Marcucci L, et al. Treatment with 5-Fluorouracil/Folinic Acid, Oxaliplatin, and Irinotecan Enables Surgical Resection of Metastases in Patients With Initially Unresectable Metastatic Colorectal Cancer[J]. Annals of Surgical Oncology, 2006, 13(1): 58-65.
|
| [32] |
Van Cutsem E,Cervantes A,Nordlinger B, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Annals of oncology, 2014, 25(Suppl 3): iii1-iii9.
|
| [33] |
Venook AP,Blanke CD,Niedzwiecki D, et al. Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma[J]. Clinical colorectal cancer, 2007, 6(7): 536-538.
|
| [34] |
Ferrero A,Viganò L,Polastri R, et al. Postoperative Liver Dysfunction and Future Remnant Liver: Where Is the Limit[J]? World Journal of Surgery, 2007, 31(8): 1643-1651.
|
| [35] |
Zorzi D,Laurent A,Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases[J]. Br J Surg, 2007, 94(3): 274-286.
|
| [36] |
Abdalla EK,Denys A,Chevalier P, et al. Total and segmental liver volume variations: Implications for liver surgery[J]. Surgery, 2004, 135(4): 404-410.
|
| [37] |
Vicente E,Quijano Y,Ielpo B, et al. Is ʺsmall for size syndromeʺ a relatively new complication after the ALPPS procedure[J]? Updates in Surgery, 2015, 67(3): 273-278.
|
| [38] |
Adam R,Laurent A,Azoulay D, et al. Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors[J]. Annals of Surgery, 2000, 232(6): 777-785.
|
| [39] |
Jaeck D,Oussoultzoglou E,Rosso E, et al. A Two-Stage Hepatectomy Procedure Combined With Portal Vein Embolization to Achieve Curative Resection for Initially Unresectable Multiple and Bilobar Colorectal Liver Metastases[J]. Annals of Surgery, 2004, 240(6): 1037-1051.
|
| [40] |
Farges O,Belghiti J,Kianmanesh R, et al. Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial[J]. Annals of Surgery, 2003, 237(2): 208-217.
|
| [41] |
Pamecha V,Nedjat-Shokouhi B,Gurusamy K, et al. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases[J]. Digestive surgery, 2008, 25(5): 387-393.
|
| [42] |
Wicherts DA,Miller R,de Haas RJ, et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases[J]. Ann Surg, 2008, 248(6): 994-1005.
|
| [43] |
Karoui M,Vigano L,Goyer P, et al. Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases[J]. The British journal of surgery, 2010, 97(9): 1354-1362.
|
| [44] |
Adam R,Laurent A,Azoulay D,et al. Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors[J]. ANNALS OF SURGERY, 2000, 232(6): 777-785.
|
| [45] |
Benoist S,Brouquet A,Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure[J]? J ClinOncol, 2006, 24(24): 3939-3945.
|
| [46] |
Brouquet A,Abdalla EK,Kopetz S, et al. High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome[J]. Journal of Clinical Oncology, 2011, 29(8): 1083-1090.
|
| [47] |
Alvarez FA,Ardiles V,Sanchez Claria R, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks[J]. J Gastrointest Surg, 2013, 17(4): 814-821.
|
| [48] |
Schadde E,Ardiles V,Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry[J]. Ann Surg, 2014, 260(5): 829-838.
|
| [49] |
Schadde E,Ardiles V,Slankamenac K, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis[J]. World J Surg, 2014, 38(6): 1510-1519.
|
| [50] |
Rhim H,Dodd GD. Radiofrequency thermal ablation of liver tumors[J]. Journal of clinical ultrasound: JCU, 1999, 27(5): 221-229.
|
| [51] |
Veltri A,Guarnieri T,Gazzera C, et al. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival[J]. La radiologiamedica, 2012, 117(7): 1139-1151.
|
| [52] |
Gillams A,Lees W. Radiofrequency ablation of colorectal liver metastases[J]. Abdominal imaging, 2005, 30(4): 419-426.
|
| [53] |
Sørensen SM,Mortensen FV,Nielsen DT. Radiofrequency ablation of colorectal liver metastases: long-term survival[J]. ActaRadiologica, 2007, 48(3): 253-258.
|
| [54] |
Adam R,Delvart Vr,Pascal Gr, et al. Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy[J]. Ann Surg, 2004, 240(4): 644-657.
|
| [55] |
Capussotti L,Muratore A,Mulas MM, et al. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases[J]. Br J Surg, 2006, 93(8): 1001-1006.
|
| [56] |
Kanas GP,Taylor A,Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors[J]. Clin Epidemiol, 2012, 4(1): 283-301.
|
| [57] |
Rubbia-Brandt L,Audard V,Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer[J]. Annals of Oncology, 2004, 15(3): 460-466.
|
| [58] |
Fernandez FG,Ritter J,Goodwin JW, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases[J]. Journal of the American College of Surgeons, 2005, 200(6): 845-853.
|
| [59] |
Pawlik TM,Olino K,Gleisner AL, et al. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome[J]. Journal of Gastrointestinal Surgery, 2007, 11(7): 860-868.
|
| [60] |
Zhu D,Zhong Y,Wei Y, et al. Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases[J]. PLoS ONE, 2014, 9(1): e86543.
|
| [61] |
de Haas RJ,Wicherts DA,Andreani P, et al. Impact of expanding criteria for resectability of colorectal metastases on short-and long-term outcomes after hepatic resection[J]. Ann Surg, 2011, 253(6): 1069-1079.
|